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Abstract
Heritable quantitative characters underline complex genetic traits. However, a single quantitative phenotype may
not be a suitably good surrogate for a clinical end point trait.
It may be more optimal to use a multivariate phenotype vector correlated with the end point trait to carry out an
association analysis. Existing methods, such as variance components and principal components, suffer from
inherent limitations, such as lack of robustness or difficulty in biological interpretation of association findings. In an
effort to circumvent these limitations, we propose a novel regression approach based on a conditional binomial
model to detect association between a single-nucleotide polymorphism and a multivariate phenotype vector. We
use our proposed method to analyze data on systolic and diastolic blood pressure levels provided in Genetic
Analysis Workshop 18. We find that the bivariate analysis of the two phenotypes yields more promising results in
terms of lower p-values compared to univariate analyses.
Background
Most clinical end point traits are governed by a set of
quantitative precursors and a single precursor is unlikely
to explain a significant amount of the variation in the end
point trait. Thus, it may be a prudent strategy to analyze a
multivariate vector of phenotypes for association mapping
of a clinical end point trait. The major statistical challenge
in the analyses of multivariate phenotypes lies in the mod-
eling of the vector of phenotypes. Univariate analyses of
the constituent phenotypes may lead to the statistical pro-
blem of multiple comparisons [1]. Likelihood-based meth-
ods, such as variance components [2,3], are susceptible to
the choice of the joint probability distribution of the com-
ponents of the vector. An alternative approach that cir-
cumvents the problem of modeling the multivariate
phenotype is to obtain a reduced univariate phenotype
using principal components [4]. However, association
results based on principal components may be difficult to
interpret biologically. We propose a novel binomial regres-
sion approach that models the likelihood of the number
of copies of the minor allele at a single-nucleotide
polymorphism (SNP) conditional on the vector of multi-
variate phenotype. We apply our proposed method to ana-
lyze systolic and diastolic blood pressure levels on
unrelated individuals using longitudinal data over four
time points provided in Genetic Analysis Workshop 18
(GAW18). We compare the association results based on a
bivariate analysis of the two phenotypes with those based
on univariate analyses.
Data description
For our analyses, we use data on systolic blood pressure
(SBP) levels and diastolic blood pressure (DBP) levels on
157 unrelated individuals along with their genotypes at
all the available 456,752 variant sites distributed over 11
autosomal chromosomes in the genome-wide association
studies data provided in GAW18. In addition to age, we
use smoking status and medication indicator (both
defined as binary variables) at each time point of exami-
nation as covariates, as these factors could be potential
confounders in the association analyses. Both the SBP
and the DBP levels are adjusted for these covariates for
each time point and the tests for association are per-
formed on the adjusted phenotypes. The adjustment and
the association analyses are based on 139 individuals, as
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data on all the covariates are not available for the remain-
ing individuals. The percentages of individuals with miss-
ing phenotype data at the different time points are 8%,
35%, 35%, and 75%, respectively. On tabulating the per-
centages of individuals with phenotype data missing at
multiple time points, we do not observe any pattern in
the missing data. For our association analyses, we impute




Imputation of missing phenotype values and covariate
adjustment
The assumption of multivariate normality provides a
computationally elegant framework for the expectation
maximization algorithm [5] to estimate parameters
when data are missing. Blood pressure levels have tradi-
tionally been believed to follow a lognormal distribution.
While the Kolmogorov-Smirnov test did not show any
significant departure from normality for the systolic and
diastolic blood pressure levels at any of the time points,
some of the p-values are very close to the threshold of
0.05. We thus use a logarithmic transformation on each
of the phenotypes to induce normality. Suppose the vec-
tor of log-transformed values of any of the two pheno-
types at the 4 time points is represented as X = (X1, X2,
X3, X4). If Y denotes the vector comprising those com-
ponents of X that are missing and Z comprising the
components that are available for an individual, Y is
estimated via an expectation maximization algorithm as
the expectation of Y conditioned on Z and is given by
μY-∑YZ∑ZZ
-1(Z-μZ), where, μY and μZ are the mean vec-
tors of Y and Z, respectively; ∑YZis the matrix of covar-
iance between Y and Z, while ∑ZZ is the dispersion
matrix of Z. At every time point, we perform a linear
regression of the log-transformed values of each of the
two phenotypes (available as well as imputed) on age,
smoking status, and medication indicator based only on
those observations for which data were available on all
the covariates and thereby obtain the residuals of each
of the regressions.
Test for association using binomial regression
The phenotypes for our association analyses are the
adjusted SBP and DBP levels at each time point
obtained using the algorithm described in the preceding
section. We propose a binomial regression framework to
test for association of a SNP with a multivariate pheno-
type. Suppose X = (X1, X2, X3,..., Xk) denotes a vector of
k phenotypes and N denotes the number of copies of
the minor allele (0, 1, or 2) at a SNP. We model the
conditional distribution of N given X as binomial with





1 + exp(β0 +
∑k
i=1 βiXi)
The test for association is equivalent to testing H0:
b1 =b2= ... =bk = 0 versus H1: not H0 and the log-like-
lihood ratio test statistic is distributed as chi-squares
with k degrees of freedom under the null hypothesis.
We compare the relative performances of 5 phenotype
vectors in detecting association: (a) T1: the adjusted
SBP levels at the 4 time points; (b) T2: the adjusted
DBP levels at the 4 time points; (c) T3: the adjusted
SBP levels summarized by the first 2 principal compo-
nents across the four time points; (d) T4: the adjusted
DBP levels summarized by the first two principal com-
ponents across the four time points; and (e) T5: the
adjusted SBP as well as the adjusted DBP levels sum-
marized by a bivariate phenotype comprising the first
2 principal components corresponding to each of the
phenotypes across the four time points. The above
choice of the principal components is motivated by the
fact that approximately 75% of the variation in each of
the two phenotypes is explained by the corresponding
first two principal components. Because the sample
size is not very large, we consider only common var-
iants for our association analyses and select only those
SNPs with a minor allele frequency of at least 0.01.
We also exclude those SNPs that provide significant
evidence of departure from Hardy-Weinberg equili-
brium (based on the Bonferroni corrected threshold at
the genome-wide level). Thus, the tests for association
based on the proposed binomial regression model are
carried out on 426,193 SNPs. To correct for multiple
testing, we use the false discovery rate (FDR) proce-
dure [6] with an overall rate of 0.05.
Results
Among the five phenotype vectors considered, the one
comprising the first two principal components of both
SBP and DBP levels (T5) provides the most promising
association findings. Table 1 presents the five most sig-
nificant association findings corresponding to each
choice of phenotype vector. The only SNP that exhibits
significant evidence of association at the genome-wide
level is rs12634258 on chromosome 3 (adjusted FDR of
0.047) with T5. We observe that this SNP also ranks
among the top five SNPs in terms of lowest unadjusted
p-values when T3 (the first two principal components of
the SBP levels at the four time points) is analyzed.
Conclusions
We have developed a binomial regression model that can
incorporate multiple phenotypes for association analysis
of the multivariate phenotype vector. The method has
several advantages: it neither involves any modeling of
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the correlation structure within the components of the
multivariate phenotype as required in likelihood-based
approaches nor does it compromise on the biological
interpretation by transforming the multivariate pheno-
type to principal components.
The SNP rs12634258 that exhibits the most promising
evidence of association with multiple definitions of the
phenotype vector is located in the intergenic region
between the genes PTPRG (receptor-type tyrosine-pro-
tein phosphatase gamma) and FHIT (fragile histidine
triad) on 3p14.2. The RNA expression in PTPRG has
been reported to be upregulated for arrhythmogenic
right ventricular cardiomyopathy in humans [7]. On the
other hand, the RNA expression of FHIT is downregu-
lated in mouse for low blood pressure [8]. Although we
obtain only one association finding that satisfies the
genome-wide FDR threshold of 0.05, it is likely that the
sample size is grossly inadequate to detect associations
for a complex phenotype.
While constructing the phenotype vectors, we had
considered the first two principal components of the
blood pressure levels across the four time points. As
mentioned earlier, these two principal components
explain approximately 75% of the total variation of
blood pressure levels across the time points. Even
though the first principal component explains approxi-
mately 55% of the variation, the first 3 principal compo-
nents explain approximately 90% of the variation.
Although for brevity we do not present the association
findings for the different choices of the principal com-
ponents, we find that the SNP rs7644778 ranks among
the top two association findings with the first principal
component of each of SBP and DBP levels across the
four time points, albeit not significant at the genome-
wide level. We note that this SNP also exhibits evidence
of association with first two principal components of
each of the two phenotypes. The SNP is located in the
gene TPRG1 (tumor protein p63 regulated 1). The RNA
expression of this gene has been reported to be upregu-
lated for cardiomyopathy in humans. On the other
hand, the five most significant findings with the first
two principal components are identical to those with
the first three principal components, but none of them
is significant at the genome-wide level. This may be
explained by the fact that the test with 3 principal com-
ponents for each of the two phenotypes has two addi-
tional degrees of freedom under the null hypothesis and
may suffer from loss in power.
Among the five phenotype vectors (T1, T2, T3, T4 and
T5), we find that T5 (ie, the phenotype that considers
both SBP as well as DBP levels simultaneously) provides
the most significant association findings (in terms of
p-value). Even though the empirical findings seem to
suggest that association analyses based on a multivariate
phenotype comprising traits modulated by common
genetic variants are likely to be more powerful than uni-
variate analyses of the constituent traits of the multivari-
ate phenotype vector, such a hypothesis can only be
validated using extensive simulations. We have per-
formed some independent simulations on 500 unrelated
individuals under a few pleiotropic bivariate phenotype
models: (a) the constituent traits have a bivariate normal
distribution, (b) both are distributed as chi-squares, and
(c) 1 trait has a normal distribution, while the other is bin-
ary. Our preliminary results based on 1000 replications
indicate that our proposed method maintains the correct
false-positive rates under all the phenotype models. We
also find that simultaneous analyses of both the pheno-
types as covariates consistently yield more power com-
pared to analyzing each univariate trait using the binomial
regression. On the other hand, the power of the proposed
method based on both phenotypes is higher, similar, or
marginally lower compared to that based on the first prin-
cipal component, depending on whether the correlation
between the traits is low (less than 0.25), medium
(between 0.25 and 0.5) or high (greater than 0.5). The
above phenomenon was observed irrespective of the
bivariate phenotype model considered. When the gene
effects are in different directions for the two phenotypes
(the minor homozygous genotype corresponds to high
Table 1 Five most significant association findings using the different phenotype vectors
T1 T2 T3 T4 T5
rs630685
(3 × 10−6, 1q42.1)
rs7928749
(1 × 10−6, 11q22.2)
rs11233253
(4.9 × 10−6, 11q14.1)
rs4239000
(9.3 × 10−6, 17q25)
rs12634258
(1 × 10−7, 3p14.2)
rs1789956
(3.5 × 10−6, 21q22.3)
rs1129174
(5.9 × 10−6, 3p25)
rs11212913
(7.7 × 10−6, 11q22.3)
rs6590606
(2 × 10−5, 11q25)
rs12153302
(1.1 × 10−6, 5q13.2)
rs3829088
(3.8 × 10−6, 9p21)
rs6791435
(6.4 × 10−6, 3p25.1)
rs9632874
(9.4 × 10−6, 9p22.3)
rs7117235
(2.1 × 10−5, 11q25)
rs12652232
(3.3 × 10−6, 5q35.3)
rs12591997
(4.1 × 10−6, 15q21.2)
rs4685160
(9.5 × 10−6, 3p25.1)
rs16960959
(1.1 × 10−5, 17p11.2)
rs1870301
(2.9 × 10−5, 15q26.2)
rs7541416
(3.9 × 10−6, 1p36.1)
rs12915086
(6.2 × 10−6, 15q26)
rs894177
(1.6 × 10−5, 3q24)
rs12634258
(1.2 × 10−5, 3p14.2)
rs12153302
(3.9 × 10−5, 5q13.2)
rs7644778
(4.6 × 10−6, 3q28)
The figures in parentheses represent the unadjusted p-values and chromosomal locations, respectively.
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values of 1 phenotype, but low values of the other pheno-
type), the first principal component performs very poorly
and may yield lower power compared to analyzing univari-
ate phenotypes. However, further simulations based on
higher dimensional phenotype vectors need to carried out
to obtain greater insights into the relative advantages of
the proposed method using the multivariate phenotype
vector over data reduction approaches such as using a sub-
set of the principal components of the phenotype vector.
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